Hypoxia as a driver of resistance to immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypoxia as a driver of resistance to immunotherapy

Published:2021-12 Issue: Volume:59 Page:100787
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Kopecka Joanna,Salaroglio Iris C.,Perez-Ruiz Elizabeth,Sarmento-Ribeiro Ana Bela,Saponara Simona,De Las Rivas Javier,Riganti Chiara

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference259 articles.

1. CLIC4/Arf6 pathway: a new lead in BMPRII inhibition in pulmonary hypertension;Abdul-Salam;Circ. Res.,2019

2. Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: a Markov analysis;Ackroyd;Gynecol. Oncol.,2021

3. Tumor hypoxia drives immune suppression and immunotherapy resistance;Ai;J. Immunother. Cancer,2015

4. Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons;Akman;J. Exp. Clin. Cancer Res.,2021

5. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation;Allen;Sci. Transl. Med.,2017

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple-pathway cGAS-STING activation collaborated with ferroptosis-induced immunogenic cell death for boosting systemic colorectal cancer immunotherapy;Nano Today;2024-12

2. A hypoxia-derived gene signature to suggest cisplatin-based therapeutic responses in patients with cervical cancer;Computational and Structural Biotechnology Journal;2024-12

3. The cellular-centered view of hypoxia tumor microenvironment: Molecular mechanisms and therapeutic interventions;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. Engineered bacteria-mediated augmentation of sialoglycan degradation strategy and immunogenic chemotherapy to boost effective cancer therapy;Chemical Engineering Journal;2024-09

5. Pharmacologic ascorbate induces transient hypoxia sensitizing pancreatic ductal adenocarcinoma to a hypoxia activated prodrug;Free Radical Biology and Medicine;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3